Kenneth R. Deans Jr.
South Carolina
Kenneth R. Deans Jr. is a Contributing Writer for The American Quorum. With 30+ years of leadership across healthcare, technology, and education, he brings an experienced, independent perspective to issues shaping America.
Healthcare
FDA Approves Bimzelx for Plaque Psoriasis After Phase 3 Trials Show 85%–91% Clear or Almost Clear Skin
Tech
U.S. Tightens AI-Chip Controls on China, Expanding Licensing to Nvidia A800, H800 and RTX 4090
Healthcare
Medicare Part B Premium Rises 5.9% to $174.70 for 2024 as Social Security COLA Slows to 3.2%
Tech
Microsoft Closes $68.7 Billion Activision Blizzard Deal After U.K. Regulator Clears Restructured Acquisition
Healthcare
Karikó and Weissman Win 2023 Medicine Nobel for mRNA Discoveries That Enabled COVID-19 Vaccines
Tech
Amazon Launches First Two Project Kuiper Satellites, Opening a 3,236-Satellite Challenge to Starlink
Healthcare
FDA Approves Subcutaneous Entyvio After 46% vs. 14% Week-52 Remission in Ulcerative Colitis Trial
Tech
Amazon Commits Up to $4 Billion to Anthropic as AWS Becomes Primary Cloud for Future Claude Models
Healthcare
CDC Recommends Maternal RSV Vaccine at 32–36 Weeks After 11-1 Vote, Adding Second Infant Protection Option
Tech
Cisco Agrees to Buy Splunk for $28 Billion, Paying $157 a Share to Expand Security and Observability
Healthcare
CDC Recommends Updated XBB.1.5 COVID-19 Vaccines for Everyone 6 Months and Older After 13-1 Advisory Vote
Tech
Google Search Antitrust Trial Opens as U.S. Challenges Default Deals on Phones and Browsers
Healthcare
FDA Approves APHEXDA After Phase 3 Trial Shows 92.5% Stem-Cell Mobilization Success in Multiple Myeloma
Tech
EU Names Six Big-Tech Gatekeepers and 22 Platform Services Under Digital Markets Act
Healthcare
Medicare Selects First 10 Drugs for Price Negotiation After $50.5 Billion in Part D Spending
Tech
OpenAI Launches ChatGPT Enterprise With Unlimited Faster GPT-4, 32K Context and No Training on Business Data
Healthcare
FDA Approves First Maternal RSV Vaccine, Cutting Severe Infant Disease 81.8% in First 90 Days
401 stories